Celon Pharma SA (CLN) — Cash Flow Quality Index
Celon Pharma SA (CLN) has a Cash Flow Quality Index of -0.03x as of March 2026. Operating cash flow of zł-4.79 Million is below net income of zł162.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Celon Pharma SA cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Celon Pharma SA Cash Flow Quality Index (2012–2020)
Historical Cash Flow Quality Index for Celon Pharma SA across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CLN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Celon Pharma SA (2012–2020)
Year-by-year earnings quality comparison for Celon Pharma SA. For live market cap and the full company financial profile, see Celon Pharma SA (CLN) market capitalisation.
| Year | Quality Index | Operating CF (PLN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 3.30x | zł70.90 Million | zł21.50 Million | ▲ +879.5% |
| 2019 | -0.42x | zł-5.05 Million | zł11.93 Million | ▼ -144.5% |
| 2018 | 0.95x | zł28.24 Million | zł29.70 Million | ▼ -3.7% |
| 2017 | 0.99x | zł25.30 Million | zł25.62 Million | ▲ +80.9% |
| 2016 | 0.55x | zł20.65 Million | zł37.81 Million | ▼ -61.2% |
| 2015 | 1.41x | zł52.37 Million | zł37.18 Million | ▲ +201.9% |
| 2014 | 0.47x | zł24.36 Million | zł52.21 Million | ▼ -0.8% |
| 2013 | 0.47x | zł8.45 Million | zł17.96 Million | ▼ -95.1% |
| 2012 | 9.65x | zł12.87 Million | zł1.33 Million | — |